Yanchun Shi | Engineering and Technology | Best Researcher Award

Assoc. Prof. Dr. Yanchun Shi | Engineering and Technology | Best Researcher Award

Institute of process engineering, Chinese Academy of Sciences | China

Dr. Yanchun Shi and collaborators Bi Wu, Sihan Sun, Jimei Zhang, and Lei Wang form a strong research team in heterogeneous catalysis and reaction engineering, focusing particularly on platinum-based catalysts for propane dehydrogenation. As corresponding author, Yanchun Shi leads the group at the Institute of Process Engineering, Chinese Academy of Sciences, and the State Key Laboratory of Molecular & Process Engineering, Beijing. Together they have authored over 41 peer-reviewed articles, accumulating more than 1,171 citations and a collective (or leading) h-index of ~20. Their academic backgrounds span chemical engineering, materials science, and computational chemistry, with advanced degrees and postdoctoral training in catalysis and reaction kinetics. They have extensive experience in catalyst synthesis, mechanistic study, and coupling experiments with modeling approaches. Their research interests include design and promotion strategies for Pt-based dehydrogenation catalysts, support effects, stability and anti-coking, and integration of machine learning approaches to predict and accelerate catalyst discovery. The group has received recognition in the catalysis community, including early-career awards, invited lectures, and funding from major national science foundations. In conclusion, their combined expertise bridging experiment, theory, and data science positions them to lead advances in optimizing stable, selective, and scalable Pt-based catalysts for industrial propane dehydrogenation.

Profile : Scopus

Featured Publications

Sattler, J. J., Ruiz‐Martinez, J., Santillan‐Jimenez, E., & Weckhuysen, B. M. (2014). Catalytic dehydrogenation of light alkanes on metals and metal oxides. Chemical Reviews, 114(20), 10613–10653.

Chen, S., Chang, X., Sun, G., et al. (2021). Propane dehydrogenation: Catalyst development, new chemistry, and emerging technologies. Chemical Society Reviews, 50(5), 3315–3354.

Zhang, W., Wang, H., Jiang, J., et al. (2020). Size dependence of Pt catalysts for propane dehydrogenation: From atomically dispersed to nanoparticles. ACS Catalysis, 10(21), 12932–12942.

Hussain, M. A., Rawan, A., James, W., Omoze, I. V., & Suljo, L. (2021). Stable and selective catalysts for propane dehydrogenation operating at thermodynamic limit. Science, 373(6551), 217–222.

Frank, B., Cotter, T. P., Schuster, M. E., Schlögl, R., & Trunschke, A. (2013). Carbon dynamics on the molybdenum carbide surface during catalytic propane dehydrogenation. Chemistry – A European Journal, 19(50), 16938–16945.

Avinash Kumar | Biology and Life Sciences | Best Researcher Award

Assist. Prof. Dr. Avinash Kumar | Biology and Life Sciences | Best Researcher Award

Long Island University Arnold and Marie Schwartz College of Pharmacy and Health Sciences | United States

Assist. Prof. Dr. Avinash Kumar, Ph.D., is an Assistant Professor at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY. With a Ph.D. in Biotechnology from the University of Pune, India, his doctoral work focused on biochemical and biophysical characterization of class II α-mannosidases. He completed postdoctoral research at the University of Mississippi Medical Center and National Center for Cell Science, India, investigating transcriptional and post-translational programs driving prostate cancer progression. His research aims to develop personalized and precision medicine strategies targeting metastatic and high-risk prostate cancer, including health disparities in African American men. Dr. Kumar utilizes high-throughput single-cell genomics, transcriptomics, and proteomics in combination with genetically engineered and xenograft mouse models, patient tissues, and complementary cell line studies. He has mentored numerous graduate, undergraduate, and Pharm.D. students, directed the Molecular Imaging Core at LIU, and actively serves on institutional committees and as a reviewer for top journals. Dr. Kumar has published 28 peer-reviewed articles, 5 book chapters, and over 20 conference abstracts, with an h-index of 17 , 873 citations, and 29 publications. He has received multiple fellowships, awards, and research grants and continues to advance translational cancer therapeutics through rigorous preclinical and mechanistic studies.

Profile : Scopus | Orcid

Featured Publications

“Reprogrammed Lipid Metabolism-Associated Therapeutic Vulnerabilities in Prostate Cancer”

“The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant,     Preclinical Mouse Model of Advanced Prostate Cancer”

“AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for       development of cancer therapeutics”

“Data from Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer”

“Supplementary Figure 1-2; Supplementary Table 1-4 from Dietary Pterostilbene for MTA1-Targeted Interception   in   High- Risk Premalignant Prostate Cancer”